Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1

ClinicalTrials.gov ID: NCT00109772

Public ClinicalTrials.gov record NCT00109772. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this multicenter, double-blind, placebo-controlled study is to evaluate the efficacy and safety of Lenalidomide in adult subjects with Complex Regional Pain Syndrome (CRPS) Type 1.

Study identification

NCT ID
NCT00109772
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene Corporation
Industry
Enrollment
184 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2005 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Apr 2008 (Actual)
Last update posted
Aug 28, 2013

2005 – 2008

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Pivotal Research Centers Peoria Arizona 85381 —
UCSD Center for Pain and Palliative Medicine La Jolla California 92093 —
Loma Linda Institution Loma Linda California 92354 —
Space Coast Neurology Palm Bay Florida 32905 —
Northwestern University Chicago Illinois 60611-2908 —
Rehab Institute of Chicago Chicago Illinois 60611 —
University of Iowa Iowa City Iowa 52242 —
Johns Hopkins Hospital Baltimore Maryland 21287 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 —
Baystate Medical Center Springfield Massachusetts 01199 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University Pain Mgmt Ctr St Louis Missouri 63141 —
Hospital for Joint Disease New York New York 10003 —
University of Rochester Medical Center Rochester New York 14642 —
UNC Hospitals University of North Carolina Chapel Hill North Carolina 27599-7010 —
Duke University Medical Center Durham North Carolina 27705 —
Womack Army Medical Center Fort Bragg North Carolina 28310 —
Carolinas Pain Institute, P.A. & the Center for Clinical Research, LLC Winston-Salem North Carolina 27103 —
Research Institute of Greater Dayton Dayton Ohio 45432 —
Oregon Health & Science University Portland Oregon 97239 —
Lehigh Valley Hospital Allentown Pennsylvania 18103 —
Knobler Institute of Neurologic Disease Fort Washington Pennsylvania 19034 —
Drexel University College of Medicine Department of Neurology Rm 7102 Philadelphia Pennsylvania 19102 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Texas Tech Medical Center Department of Anesthesiology Lubbock Texas 79430 —
University of Virginia Pain Management Center Charlottesville Virginia 22903 —
Swedish Pain Services Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00109772, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 28, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00109772 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →